These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35608055)

  • 1. The role of statin therapy in COVID-19.
    Daniels LB; Kumar K
    Expert Rev Cardiovasc Ther; 2022 Jun; 20(6):415-417. PubMed ID: 35608055
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: Direct and Indirect Mechanisms of Statins.
    Pawlos A; Niedzielski M; Gorzelak-Pabiś P; Broncel M; Woźniak E
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
    Barkas F; Milionis H; Anastasiou G; Liberopoulos E
    Med Hypotheses; 2021 Jan; 146():110452. PubMed ID: 33333472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
    Jia X; Virani SS
    J Clin Lipidol; 2021; 15(3):399-401. PubMed ID: 33994121
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases.
    Zahedipour F; Guest PC; Majeed M; Al-Rasadi K; Jamialahmadi T; Sahebkar A
    Methods Mol Biol; 2022; 2511():273-284. PubMed ID: 35838967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 8. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.
    Surma S; Banach M; Lewek J
    Lipids Health Dis; 2021 Oct; 20(1):141. PubMed ID: 34689776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and SARS-CoV-2 disease: Current concepts and possible benefits.
    Minz MM; Bansal M; Kasliwal RR
    Diabetes Metab Syndr; 2020; 14(6):2063-2067. PubMed ID: 33120281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19).
    Li SD; Zhang SY; Peng B
    Chin Med J (Engl); 2020 Nov; 134(4):407-409. PubMed ID: 33617183
    [No Abstract]   [Full Text] [Related]  

  • 12. The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.
    Chow R; Im J; Chiu N; Chiu L; Aggarwal R; Lee J; Choi YG; Prsic EH; Shin HJ
    PLoS One; 2021; 16(6):e0253576. PubMed ID: 34166458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).
    Subir R; Jagat J M; Kalyan K G
    Diabetes Metab Syndr; 2020; 14(5):1225-1229. PubMed ID: 32683320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis.
    Permana H; Huang I; Purwiga A; Kusumawardhani NY; Sihite TA; Martanto E; Wisaksana R; Soetedjo NNM
    Pharmacol Rep; 2021 Jun; 73(3):769-780. PubMed ID: 33608850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.
    Kashour T; Halwani R; Arabi YM; Sohail MR; O'Horo JC; Badley AD; Tleyjeh IM
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):37-50. PubMed ID: 33406943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection.
    Ferrara F; Vitiello A
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):958-965. PubMed ID: 33779831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?
    Vuorio A; Kovanen PT
    J Intern Med; 2021 Oct; 290(4):931-933. PubMed ID: 34133038
    [No Abstract]   [Full Text] [Related]  

  • 18. Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis.
    Ghosh D; Ghosh Dastidar D; Roy K; Ghosh A; Mukhopadhyay D; Sikdar N; Biswas NK; Chakrabarti G; Das A
    Sci Rep; 2022 Apr; 12(1):6241. PubMed ID: 35422113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and Covid-19: The Neglected Front of bidirectional effects.
    Hussien NR; Al-Niemi MS; Al-Kuraishy HM; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S133-S136. PubMed ID: 35130236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis.
    Onorato D; Pucci M; Carpene G; Henry BM; Sanchis-Gomar F; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):392-399. PubMed ID: 33482680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.